Project Grant R43AA028456

Award Date 11/5/20
Completion Date 10/31/22
Dollars Obligated $672K
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), funded under the Alcohol Research Programs (CFDA 93.273), provides $399,293 to Echelon Biosciences Inc. to develop a prototype rapid point-of-care phosphatidylethanol (PEth) competitive lateral flow immunoassay. PEth is considered the most reliable long-term biomarker for detecting alcohol consumption, but current testing methods are costly and have slow turnaround times. The goal of this Phase I...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) grant program, will support the development and testing of a novel wearable medical device to treat anxiety and stress in individuals with Alcohol Use Disorder (AUD). The $385,000 award to Soovu Labs Inc. will fund a two-phase project to determine optimal stimulation parameters for activating C-tactile fibers and TRPV-1 channels in the peripheral...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $511,798 was awarded to Kilele Health Inc. on June 15, 2022 to develop continuous diagnostic monitoring platforms beyond glucose sensing. Unlike existing enzymatic glucose sensors, the company will utilize electrochemical aptamer sensors that can rapidly measure other molecules in the body with high specificity and sensitivity. The aim is to address limitations that have...
This $516,146 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) aims to examine alcohol-induced blackouts and other consequences among young adult drinkers using transdermal alcohol concentration (TAC) biosensors. The research will: 1) assess whether TAC features can predict alcohol-induced blackouts and other consequences, and 2) investigate social, psychological, and biological factors related to TAC...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), aims to enhance the understanding and prediction of heavy drinking episodes during initial recovery from alcohol use disorder (AUD). The $1,373,036 award, spanning September 2024 to August 2029, will leverage wearable biosensors and artificial intelligence to develop real-time predictive models that can anticipate periods of heightened drinking risk...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, provides $613,777 to The Pennsylvania State University to conduct a prospective examination of transdermal alcohol concentration (TAC) features as predictors of alcohol-related consequences and alcohol use disorders (AUD) among young adults. The research will use a large-scale measurement burst design consisting of eight...
The National Institute on Drug Abuse (NIDA) awarded a $800,000 Cooperative Agreement under the Drug Use and Addiction Research Programs (CFDA 93.279) to Biosensics LLC, a digital health technology company, to develop ODALERT - an innovative wearable device designed to detect and alert users and first responders of potential opioid overdoses. The project aims to create a wearable sensor that continuously monitors respiratory patterns and triggers an alarm and emergency notification when it...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $105,057 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Temple University-Of The Commonwealth System of Higher Education. The grant supports a 22-month prospective study to investigate smartwatch-based predictors of binge drinking onset in first-year college students. The study aims to examine how physical activity, sleep, and heart rate variability measured via smartwatches can prospectively predict the...
The National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded a $450,000 Project Grant to the Texas A&M Engineering Experiment Station (Tees) to develop an injectable, grain-of-rice size glucose biosensor for continuous blood sugar monitoring. The key products or services to be provided under this 3-year grant include: Developing an injectable glucose biosensor comprised of a self-cleaning membrane and a near-infrared fluorescence...
The National Institute of Standards and Technology (NIST) awarded a $398,622 Cooperative Agreement under its Science, Technology, Business and/or Education Outreach program (CFDA 11.620) to Interlink Electronics, Inc. The purpose of this Phase II project is to produce a prototype electrochemical gas sensor that can be manufactured using high-volume, roll-to-roll or lamination processes. The expected outcome is the development of advanced digital gas sensing modules that can be integrated into...

A WEARABLE ELECTROCHEMICAL ALCOHOL SENSOR - PROJECT SUMMARY/ABSTRACT MEASURING ALCOHOL CONSUMPTION IS IMPORTANT TO INDIVIDUAL HEALTH AND THE PREVENTION OF ADVERSE CONSEQUENCES OF DRINKING. THERE ARE TREMENDOUS NEEDS FOR WEARABLE ALCOHOL CONTINUOUS SENSING DEVICES THAT ARE ACCURATE, MINIMAL- OR NON-INVASIVE, UNOBSTRUCTIVE AND AFFORDABLE. HOWEVER, EXISTING TECHNOLOGIES CANNOT PROVIDE ALCOHOL SENSORS WITH ALL SPECIFICATIONS DESIRED BY WEARABLE DEVICES, INCLUDING SIZE, POWER, SENSITIVITY, SPECIFICITY, SAFETY, MANUFACTURABILITY AND COST. THE PROPOSED PROJECT IS TO DEVELOP AN ALCOHOL SENSOR SUITABLE FOR WEARABLE APPLICATIONS BY INNOVATING ELECTROCHEMICAL ALCOHOL SENSORS. THE INNOVATION USES MICROFABRICATION TECHNIQUES TO ACHIEVE HIGH SENSITIVITY, HIGH SAFETY, GOOD MANUFACTURABILITY AND LOW COST WITH A MINIATURIZED MEMBRANELESS STRUCTURE. THE CATALYTIC EFFECT OF THE DESIGNED ELECTROLYTE-ELECTRODE INTERFACE ACHIEVES HIGH SENSITIVITY AND HIGH SELECTIVITY. THE SIZE OF THE SENSOR IS LESS THAN 2X2 MILLIMETERS, CAN UNLOCK MANY POSSIBILITIES FOR WEARABLE, SMARTPHONE, AND AUTOMOBILE FOR ALCOHOL DETECTION IN BREATH, INTERSTITIAL FLUID, OR BLOOD. IN THIS PROJECT, WE AIM TO DEMONSTRATE THE TECHNOLOGY BY AN EXAMPLARY RING FORM FACTOR WIRELESS POWERED WEARABLE DEVICE THAT CAN ACCURATELY AND CONTINUOUSLY MONITOR THE ALCOHOL LEVEL IN BODY FLUID. IN PHASE I, IN ADDITION TO THE ALCOHOL SENSOR, A MINIMAL INVASIVE BIOCOMPATIBLE MICRONEEDLE ARRAY IS DESIGNED TO PAINLESSLY SAMPLE AND DELIVER THE INTERSTITIAL FLUID TO THE SENSOR. THE MICRONEEDLE ARRAY IS DESIGNED TO BE PROCESSED ALONG WITH THE SENSOR ON THE SAME SILICON SUBSTRATE. THE ENTIRE PROCESS IS COMPATIBLE WITH THE FABRICATION OF COMPLIMENTARY OXDE METAL SEMICONDUCTOR (CMOS), ALLOWING THE FURTHER MONOLITHIC INTEGRATION OF THE MICRONEEDLE ARRAY, THE ALCOHOL SENSOR, AND THE CMOS SENSOR READOUT INTEGRATED CIRCUIT (IC) IN PHASE II.

Posted 11/5/20, 12:00 AM